BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 77CR

ABSTRACT: To study the effect of inhibiting AR and HNF1A/HNF4G activity either alone or in combination on the growth of CRPC PDX LuCaP 77CR.

ORGANISM(S): Homo sapiens

PROVIDER: GSE253805 | GEO | 2025/01/18

REPOSITORIES: GEO